Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-18 Zalevsky Jonathan Chief R&D Officer Sale −186 $71.98 $13K 9,570
2026-07-24 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +16,500 16,500
2026-06-30 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −5,681 $70.00 $398K 9,756
2026-06-15 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −5,538 $60.71 $336K 15,437
2026-05-19 Zalevsky Jonathan Chief R&D Officer Sale −199 $65.51 $13K 20,975
2026-02-18 Zalevsky Jonathan Chief R&D Officer Sale −180 $73.00 $13K 21,174
2026-01-20 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −3,867 $35.67 $138K 21,354
2025-12-22 Zalevsky Jonathan Chief R&D Officer Grant or award +6,250 25,221
2025-12-22 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +25,000 25,000
2025-11-25 Zalevsky Jonathan Chief R&D Officer Sale −1,157 $54.28 $63K 18,971
2025-11-21 Zalevsky Jonathan Chief R&D Officer Grant or award +2,666 20,128
2025-11-21 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +4,766 4,766
2025-09-04 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −793 $32.43 $26K 18,390
2025-09-04 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −432 $33.60 $15K 17,958
2025-09-04 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −189 $34.41 $7K 17,769
2025-09-04 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −307 $35.69 $11K 17,462
2025-09-02 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −485 $30.10 $15K 19,183
2025-08-19 Zalevsky Jonathan Chief R&D Officer Sale −725 $26.59 $19K 19,668
2025-08-19 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +16,666 16,666
2025-05-19 Zalevsky Jonathan Chief R&D Officer Sale −10,712 $0.67 $7K 305,892

Page 1 of 4 · 63 trades